Ah yes of course, excellent point. There's bound to be higher rates of persistency if the main cause of dropouts (presumably GI issues and diarrhoea)is absent or minimised in 2591.
Also there's the possibility of Retts patients migrating to 2591 at a later date which could also improve persistency rates there too. Anyway you look at 2591, it just shines all around.
- Forums
- ASX - By Stock
- NEU
- Ann: J.P. Morgan Healthcare Conference recap
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.00%
!
$12.85

Ann: J.P. Morgan Healthcare Conference recap, page-16
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.85 |
Change
0.000(0.00%) |
Mkt cap ! $1.598B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16 | $14.07 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.07 | 592 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16 | 14.070 |
6 | 302 | 13.630 |
1 | 6 | 13.500 |
8 | 750 | 13.490 |
1 | 1 | 13.230 |
Price($) | Vol. | No. |
---|---|---|
12.070 | 68 | 3 |
12.210 | 87 | 1 |
12.220 | 79 | 2 |
12.470 | 38 | 1 |
12.510 | 639 | 1 |
Last trade - 10.04am 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online